Search Results

On this page: Medications to treat Parkinson’s Medication is specific to you  Medications play a key role in managing motor and non-motor symptoms of Parkinson’s. Because Parkinson’s affects everyone differently, treatment plans need to be personalized. Not everyone will experience the same symptoms or to the same degree, and only the symptoms that impact your […]

Updated: June 17 2025 Parkinson’s is driven by decreased levels of dopamine, a chemical produced in the brain responsible for maintaining smooth movement and motor control, as well as influencing memory, feelings of pleasure, and motivation. In Parkinson’s, this neurodegeneration – a progressive loss of dopamine-producing neurons – can cause a range of motor and […]

Slowing down or modifying disease progression Current drugs for Parkinson’s treat the symptoms but do not stop the progression. One of the biggest investments in Parkinson’s research is in trying to find a drug that will slow down or modify the disease progression. Azilect® The drug rasagiline (Azilect®) was studied recently to determine if it […]

At the University of Montreal, Professor Louis-Eric Trudeau investigates the earliest potential causes of Parkinson’s disease, at the cellular level. His project is funded by the Saucier-van Berkom Parkinson Quebec Research Fund with contributions from Parkinson Newfoundland & Labrador, in the amount of $49,748.00 for 1 year. He is exploring the possibility that Parkinson’s is […]

At McGill University, Frédérique Larroquette, a PhD student, is conducting basic research to determine why only the brain cells that produce dopamine are vulnerable to the stressors that produce Parkinson’s disease. Larroquette is transforming stem cells into dopaminergic brain cells to study the three puzzle pieces known to play some role in the development of […]

Researchers in Montréal, led by Jacques Drouin, D.Sc., recently uncovered a mechanism regulating dopamine levels in the brain by working on a mouse model of late onset Parkinson’s disease. The study, conducted in collaboration with Dr. Rory A. Fisher from the department of pharmacology at the University of Iowa Carver College of Medicine, was published […]

Brain cells don’t just let any proteins through their membranes, but unfortunately, they make an exception for a toxic form of protein called alpha-synuclein that’s at the heart of Parkinson’s disease. Researchers know misshapen or mutated forms of alpha-synuclein form clumps and ultimately kill brain cells that produce dopamine. Dopamine is the signalling chemical that […]

When Barbara Salsberg Mathews tweeted a video of herself dancing on February 25, 2023, she didn’t expect to receive such an amazing response. Within just a few short days, her tweet “Parkinson’s Disease can’t stop me from dancing” had received over 15,000 views.   Even more amazingly, many other people living with Parkinson’s began replying by […]

By Dr. Isabelle Boileau I chose neuroscience because I wanted to understand how minute changes in brain chemistry can lead to remarkable changes in behaviour and function and can lead to disease. Motivated by my desire to learn about the neurochemistry of human behaviour, the first conscious decision of my scientific career was to work […]